drugset / Trial / NCT05189873
GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is conducted at Arash Women's Hospital on all women undergoing the frozen embryo transfer cycle. Patients who signed informed consent will be randomly divided into two groups. The first group will receive GnRH agonist plus hormone replacement therapy for endometrial preparation. Group 2 will receive hormone replacement therapy. The random allocation and final outcome of the study will be assessed by a person who is unaware of the study process. Also, the statistician will be unaware of the study process
Timeline
- Start
- 2021-06-10
- Primary completion
- 2022-01-03
- Completion
- 2022-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Superfect | Unknown | 0.25 ml | Other |
| Background | Estradiol | Other / unclassified | 6 mg | — |
| Background | Progesterone | Other / unclassified | — | Other |